tm
Seeing Is Believing
tm
Seeing Is Believing
Aeglea Bio Therapeutics's activity chart (see below) currently has 38 price targets and 38 ratings on display.
Analysts average stock forecasts to be materialized ratio is 39.51% with an average time for these price targets to be met of 55.2 days.
Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 13-Nov-2023. First documented stock forecast 02-May-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Aug-2023
$12
$-15.6 (-56.52%)
$12.5
2 years 11 months 19 days ago
(13-Nov-2023)
2/3 (66.67%)
$1.82 (17.88%)
10
Buy Since 25-Jul-2023
$23
$-4.6 (-16.67%)
$23
3 years 9 days ago
(23-Oct-2023)
3/3 (100%)
$10.59 (85.33%)
120
Hold Since 03-Mar-2023
$25
3 years 7 months 29 days ago
(03-Mar-2023)
1/7 (14.29%)
$9.4 (60.26%)
150
Hold Since 27-Oct-2022
$37.5
$9.9 (35.87%)
4 years 5 days ago
(27-Oct-2022)
1/6 (16.67%)
$23.25 (163.16%)
14
Buy Since 04-Feb-2022
4 years 4 months 29 days ago
(03-Jun-2022)
3/3 (100%)
$-30.5 (-77.22%)
161
What is AGLE (Aeglea Bio Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on AGLE (Aeglea Bio Therapeutics)?
Which analyst has the most public recommendations on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most bullish on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most reserved on AGLE (Aeglea Bio Therapeutics)?
